Navigation Links
Small Changes in Two Genes May Trigger Breast Cancer
Date:5/13/2010

Testing for genetic variations might reveal women most at risk, researchers say

THURSDAY, May 13 (HealthDay News) -- Slight changes in the expression of two common genes trigger cellular changes that can lead to breast cancer, a new study finds.

The researchers adjusted the expression of the genes -- estrogen receptor alpha and p53 -- in mice but said the tweaks they made in the rodents likely mimic natural variations of the two genes in women.

"It was believed that both of these genes only act once breast cancer had developed," lead investigator Dr. Priscilla A. Furth, a professor of oncology and medicine at Lombardi Comprehensive Cancer Center at Georgetown University Medical Center, said in a news release. She added that p53 mutations are found in many cancers, including breast cancer, and that a majority of breast cancer patients have over-expression of this common estrogen receptor.

"What wasn't known is that different levels of expression of these genes can help launch the cellular changes that lead to breast cancer. That suggests that testing women for their own variations in these genes might potentially give us a clue as to which women are at higher risk for development of breast cancer," she said.

In this study, Furth and colleagues developed mice that lacked one copy of the p53 gene (mice and humans have two copies of this gene, one from each parent). This gene regulates cell growth and is a powerful tumor suppressor. Changes in p53 are seen in 30 percent to 40 percent of breast cancer cases.

In another group of mice, the researchers boosted expression of estrogen receptor alpha by twofold, a level of increase sometimes seen in women. Nearly 70 percent of breast cancer patients have estrogen receptor-positive breast cancer, they noted.

Both groups of mice showed significant precancerous changes in breast tissue. Those changes were even more evident in mice that had one p53 gene as well as twice as much estrogen receptor expression.

"Normal breast tissue functioning requires a balance of cell growth and cell death, and in this study we found that both deregulated estrogen receptor function and p53 expression independently, and in combination, altering this balance and transforming cells," Furth said.

"These are not the only two molecules that are responsible for breast cancer development, but they are important and they can potentially provide us with an early warning or even with prevention strategies," she added.

The study was published online May 13 in the journal Cancer Research.

More information

The U.S. Centers for Disease Control and Prevention has more about breast cancer.



-- Robert Preidt



SOURCE: Georgetown University Medical Center, news release, May 13, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. IPC The Hospitalist Company, Inc. to Present at Deutsche Bank 2010 Small and Mid Cap Conference
2. Omnetics Nano-to-Flex Connectors Solve Big Problems in Small Spaces
3. Landrieu, Lincoln, Stabenow, Small Business Owners Discuss Positive Impact of Health Reform on Small Businesses
4. Even a Small Dietary Reduction in Salt Could Mean Fewer Heart Attacks, Strokes and Deaths
5. Small Cuts in Salt Intake Spur Big Drops in Heart Trouble
6. NSBA 2009 Year-End Economic Report: Small Businesses Still Struggling
7. NCCN Guidelines for Non-Small Cell Lung Cancer Updated to Incorporate Maintenance Therapy
8. Union Tax Deal a Slap in the Face to Small Business
9. Smaller Airports May Endanger Health
10. New Disability Income Insurance Options Provide More Choice for Californias Small Business Owners
11. Pay a Dollar, Dress a Child: Helping Struggling Families with Small Donations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ... the introduction of an innovative new design of the shoulder pad. The shoulder ... maximum comfort while controlling your pain while using cold therapy. By utilizing ice and ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information ... we intend to develop to enable prevention of a major side effect of ... loss, especially in pediatric patients. For cisplatin, hearing loss is FDA listed on-label ...
(Date:10/12/2017)... Washington, D.C. (PRWEB) , ... October 12, 2017 , ... ... of their peers in Washington, D.C., for the 49th Congress of the International ... Ph.D ., Vice President of the Center for Cancer and Blood Disorders ...
(Date:10/12/2017)... ... October 12, 2017 , ... Health ... interactive health literacy software tool, and the Cancer Patient Education Network (CPEN), an ... education, today announce a new strategic alliance. , As CPEN’s strategic partner, ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... the University of California Berkeley, and other leading institutions in announcing the launch ... of institutions to change the way animals are raised for food. , Founding ...
Breaking Medicine News(10 mins):
(Date:10/4/2017)... 4, 2017  South Korean-based healthcare product Development Company ... "cprCUBE" on Kickstarter. The device will educate the user ... with better efficiency compared to the dated and pricey ... on efficacy of the compression for a more informed ... goal to raise $5,000. ...
(Date:10/2/2017)...  AllianceRx Walgreens Prime, the combined central specialty pharmacy ... benefit manager Prime Therapeutics LLC (Prime), today officially began ... unveiling of new signage at its headquarters in ... a few other company-owned facilities across the country. This ... of whom will begin to see the AllianceRx Walgreens ...
(Date:9/27/2017)... their devotion to personalized service, SMP Pharmacy Solutions announces their ... South Florida Business Journal,s 50 Fastest-Growing Companies, and listed for ... specialty pharmacy has found its niche.  To that end, the ... by SFBJ as the 2017 Power Leader in Health Care. ... award in October, Bardisa said of the three achievements, "It,s ...
Breaking Medicine Technology: